Obermatt

Green Cross

KSC:005250 · KR7005250006
BiotechnologyMedium

360

28
Medium confidence — indicative
Profit price49
Owner Earnings Yield1
Dividend Yield1
Price/Sales97
EV / Gross Profit56
Price/Book91
Return on Capital85
Cash Return on Capital86
Return on Equity89
EBIT Margin76
Gross Profitability63
Accruals45
Owner Earnings Margin81
Sales growth46
Profit growth94
Reinvestment36
Price momentum26
Debt load14
Refinancing100
Debt Payback1
Liquidity32
Analyst ratings
Expectations trend
Market mood29
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Green Cross doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountrySouth Korea
IndustryBiotechnology
SizeMedium
TypePublic Company
ExchangeKOSE
Websitegccorp.com
ISINKR7005250006
Last UpdateApr 2, 2026
Themes
HematologyImmunologyOncologyVaccinesInfectious DiseasesBiopharmaHealth CarePharmaceuticalWellness

Description

Analysis

Quality compounder

GC Corp. is a quality compounder: a well-run business trading at a price that reflects what it is worth.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is fragile. The company scores 6/20 on our value-creation score: not creating value.

What to watch: The financial cushion is thinner than comfortable. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
49
2026

All-time high

84

Mar 2026

All-time low

49

Jun 2026

Average rank

67

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
97
Price/Earnings
100
Price/Book
91
Dividend Yield
1
Value (overall)
69

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Green Cross with its peers
Ilsung IS
KSC:003120
59
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Chong Kun Dang
KSC:185750
55
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
GC Biopharma
KSC:006280
52
CountrySouth Korea
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Sinovac Biotech
NSQ:SVA
CountryChina
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Hanall Biopharma
KSC:009420
30
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Handok
KSC:002390
15
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →